Low Dose Human Chorionic Gonadotropin Maintains Intratesticular Testosterone in Normal Men following Gonadotropin Suppression
Andrea D. Coviello(Boston University), J.P. Jarow(Johns Hopkins University), Xiaohua Yan(First Affiliated Hospital of Jiangxi Medical College), Bradley D. Anawalt(University of Washington), Karen L. Herbst(The Roxbury Institute), Alvin M. Matsumoto(University of Washington), William W. Wright(Johns Hopkins University), W. J. Bremner(University of Washington), T. R. Brown(Johns Hopkins University), P.L. Sutton(University of Washington), B. R. Zirkin(Johns Hopkins University), John K. Amory(University of Washington)
Cited by 0
Related Papers
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
|The Journal of Clinical Endocrinology & Metabolism|2002|1.8k
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society* Clinical Practice Guideline
|The Journal of Clinical Endocrinology & Metabolism|2018|1.6k
Endocrine-Disrupting Chemicals and Public Health Protection: A Statement of Principles from The Endocrine Society
|Endocrinology|2012|1.2k
Effects of Testosterone Treatment in Older Men
|New England Journal of Medicine|2016|864